← Back to Search

Other

Perioperative Pain Management for Shoulder Arthritis

N/A

Waitlist Available

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial looks at improving the effectiveness and efficiency of shoulder replacement surgery. It looks at the use of perioperative pain management strategies and careful patient selection to reduce length of stay and improve effectiveness.

Who is the study for?

This trial is for individuals undergoing total shoulder arthroplasty, who have conditions like osteoarthritis, rheumatoid arthritis, rotator cuff issues or fractures. It's not specified who can't join the trial.Check my eligibility

What is being tested?

The study tests a pain management cocktail during shoulder replacement surgery. This mix includes saline solution, ropivacaine (a numbing drug), morphine (painkiller), epinephrine (to reduce bleeding) and ketorolac (for inflammation).See study design

What are the potential side effects?

Possible side effects may include nausea from morphine; numbness or weakness due to ropivacaine; increased heart rate from epinephrine; stomach issues or kidney problems from ketorolac.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain VAS

Secondary outcome measures

ASES Shoulder Score

Analgesia Diary

Constant Score

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Local Infiltration AnesthesiaExperimental Treatment1 Intervention

High volume local infiltration anesthesia with 100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine (40 ml), 10 mg morphine (10 mg/ml), 0.1 mg of epinephrine (0.1 mg/ml), and 30 mg of ketorolac (30 mg/ml) divided equally into a 20 ml five-zone field infiltration into the suprascapular notch/posterior capsule (suprascapular and axillary nerves), coracobrachialis muscle, anterior deltoid muscle, superior pectoralis major muscle, and skin incision at the conclusion of the procedure by the treating surgeon.

Group II: Regional Brachial Plexus BlockadeActive Control1 Intervention

Ultrasound guided brachial plexus blocade with 10 ml of 0.5% ropivacaine using a high frequency linear array transducer.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor

658 Previous Clinical Trials

413,578 Total Patients Enrolled

1 Trials studying Shoulder Arthritis

90 Patients Enrolled for Shoulder Arthritis

Media Library

Perioperative Pain Management (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05908851 — N/A

Shoulder Arthritis Research Study Groups: Local Infiltration Anesthesia, Regional Brachial Plexus Blockade

Shoulder Arthritis Clinical Trial 2023: Perioperative Pain Management Highlights & Side Effects. Trial Name: NCT05908851 — N/A

Perioperative Pain Management (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908851 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the upper age limit for inclusion in this research project 45 years or older?

"According to the entry requirements, participants are required to be between 18 and 80 years old. Additionally, there are 60 trials available specifically for minors while 374 clinical studies exist targeting an elderly demographic."

Answered by AI

Are there any opportunities for me to take part in this trial?

"Prospective members of this medical trial must have shoulder joint arthrosis and be within the age range of 18 to 80 years. At the current time, there is a need for about eighty individuals."

Answered by AI

Is there still availability for individuals seeking to enroll in this clinical trial?

"According to clinicaltrials.gov, the submission of this medical experiment is no longer open - it was first posted on August 1st 2023 and last edited June 14th 2023. Although registration for this trial has closed, there are currently 428 other studies recruiting participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Perioperative Pain Management for Total Shoulder Arthroplasty: A Pilot Non-Inferiority Trial

2023. "Perioperative Pain Management for Total Shoulder Arthroplasty: A Pilot Non-Inferiority Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05908851.